Moreover, our study indicated that compared to control group, the reduction of IL-6, TNF-α as well as CRP levels in the study group were more significant, reflecting that folic acid and vitamin B12 plus rosuvastatin could improve the inflammatory response in treating CHD complicated with hyperlipidemia. Here, IL6 is linked to hyperlipidemia.